Trials / Completed
CompletedNCT06132243
Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
A Single-dose, Randomized, Open-label, Repeated Cross-over Pharmacokinetic Comparison Study of Two Formulations of Jaktinib Hydrochloride Tablets in Healthy Adult Volunteers Under Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic Characteristics of two formulations of Jaktinib Hydrochloride Tablets in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Jaktinib Hydrochloride Tablets | Orally, one tablet at a time |
Timeline
- Start date
- 2023-11-29
- Primary completion
- 2023-12-20
- Completion
- 2023-12-20
- First posted
- 2023-11-15
- Last updated
- 2024-01-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06132243. Inclusion in this directory is not an endorsement.